CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 4 Grant or award Director acquired 1,004 shares (grant or award)
- 4 Grant or award Director acquired 1,004 shares (grant or award)
- 4 Grant or award Director acquired 1,004 shares (grant or award)
- 4 Grant or award Director acquired 1,004 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market buy President and COO bought 2,500 shares at $82.76 ($206,910)
- 4 Option exercise Chief Executive Officer acquired 8,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- 425 Deal Prospectus/Communication re Business Combination
Page 22 of 115 · 2,300 filings